Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Scorpius Holdings Inc (SCPX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Scorpius Holdings's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.1859 +0.0059    +3.28%
04/05 - Closed. Currency in USD ( Disclaimer )
After Hours
0.1810
-0.0049
-2.6358%
8:53:45 - Real-time Data
  • Volume: 402,441
  • Bid/Ask: 0.1825 / 0.1900
  • Day's Range: 0.1800 - 0.1899
Type:  Equity
Market:  United States
Scorpius Holdings 0.1859 +0.0059 +3.28%

Scorpius Holdings Inc Company Profile

 
Get an in-depth profile of Scorpius Holdings Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

77

Equity Type

ORD

Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.

Contact Information

Address 627 Davis Drive Suite 400
Morrisville, 27560
United States
Phone 919 240 7133
Fax -

Top Executives

Name Age Since Title
Roger B. Cohen - - Member of Scientific & Clinical Advisory Board
John K. A. Prendergast 70 2016 Independent Lead Director
John Monahan 78 2009 Independent Director
Justin Stebbing - - Chief Medical Advisor and Member of Scientific & Clinical Advisory Board
Edward B. Smith 49 2010 Independent Director
Llew Keltner 74 - Member of Scientific & Clinical Advisory Board
Gary Acton 65 - Member of Scientific & Clinical Advisory Board
Robert B. Levy - 2017 Member of Scientific Advisory Board
Anthony W. Tolcher - 2018 Scientific Advisory Board Member
Robert S. Negrin - 2017 Member of Scientific Advisory Board
Andrew C. Webber - 2021 Member of Biothreat Advisory Board
Mark Pryor - 2021 Member of Biothreat Advisory Board
David Lasseter - - Member of Biothreat Advisory Board
Greg Burel - 2022 Member of Biothreat Advisory Board & Senior Advisor
Jack Kingston - - Member of Biothreat Advisory Board
Gregory Koblentz - 2021 Member of Biothreat Advisory Board
Richard Bowman Myers 82 2022 Chairman of BioThreat Advisory Board
Jeffrey Alan Wolf 61 2008 Founder, Chairman & CEO
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SCPX Comments

Write your thoughts about Scorpius Holdings Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email